Connect with us
Anglostratits

Health

Breast Cancer Cost Seven African Economies Over $10 Billion in Lost Productivity, New Analysis Shows

Published

on

Cancer

The research also showed how every dollar invested in innovative cancer treatments can generate up to USD12.40 in economic returns, primarily by restoring women’s productivity

NAIROBI, Kenya, March 11, 2026/APO Group/ —

  • Findings were presented at the 2026 Roche Africa Press Day in Nairobi (https://www.Roche.com), which convened journalists from nine African countries with policymakers and health experts
  • The event focused on the theme “Health is Wealth,” exploring how investment in women’s health can drive economic growth and stronger health system
  • Research reveals every dollar invested in innovative breast cancer treatments generates up to USD 12.40 in economic return

 

Investing strategically in the health of Africa’s women will unlock billions of dollars in economic growth, as well as saving lives and strengthening communities, according to speakers at Africa Press Day held in Nairobi on March 4-5.

Convened by healthcare company Roche, the 2026 edition of Africa Press Day gathered journalists from nine African countries, alongside policymakers, economists, health experts, and development finance leaders. They discussed evidence and case studies proving how public private partnerships and strategic investments in health systems, especially in women’s health, can build human capital, productive workforces, and resilient economies.

In a keynote address, Kenya’s Principal Secretary State Department for Medical Services, Ministry of Health, Dr Ouma Oluga, urged media to help shape an informed narrative about improving health: “When a health story is being told, what is most important to portray? Is it what is killing people? Is it the solutions that should stop what is killing people? Or is it the in-between—the administrative, resource, and policy actions that link the two?”

As African governments increasingly focus on economic diversification and productivity, speakers argued that health investment must be treated as core economic policy — not simply a social expenditure.

Health is Wealth: The Economic Case for Investment 

Kenya’s EMPOWER initiative highlights how partnership and digital innovation can create a step-change in women’s healthcare

To demonstrate the returns on investing in women’s health, Roche unveiled research (http://apo-opa.co/4b2mjzX) from the WifOR Institute showing how the aggressive form of HER2+ breast cancer (responsible for up to 20% of cases on the continent) caused over USD10 billion in lost productivity across seven African countries (Algeria, Côte d’Ivoire, Kenya, Morocco, Nigeria, South Africa, and Tunisia) from 2017-2023.

Nearly 90% of these losses came from women in their prime working years. The research also showed how every dollar invested in innovative cancer treatments can generate up to USD12.40 in economic returns, primarily by restoring women’s productivity and allowing for longer healthy working lives.

Maturin Tchoumi, Pharma International Area Head, Roche Africa, said: “Breast cancer is a rising threat to African societies and economies. The evidence clearly shows that investing in women’s health is not a cost or a social expense, but a powerful economic driver that underpins productivity, resilience, equity, and sustainable growth across the continent.”

Health Is Equity: Closing the Diagnosis Gap

Extending quality cancer care to all African women, regardless of geography or income, was a key theme of the event. This included closing the gaps in breast cancer screening and early diagnosis that lead to around 77 per cent (http://apo-opa.co/4cFcF7F) of African women being diagnosed in the later stages of the disease when it is much harder – and more expensive – to treat.

H.E. Dorothy Nyong’o, First Lady of Kisumu County, Chair of the Africa Cancer Foundation, and member of the Africa Breast Cancer Council, highlighted Kenya’s EMPOWER (http://apo-opa.co/4s7GuCH) initiative for breast and cervical cancer (which delegates visited at a local hospital). It has digitised the patient journey via 76 physical and virtual clinics, speeding up diagnosis and treatment. Since its founding in 2019, EMPOWER has reached over 235,000 women, enabling 3,225 to receive treatment, and been adopted by the National Cancer Institute of Kenya as a nationally integrated platform.

H.E. Dorothy Nyong’o said: “Tackling breast cancer is not just a moral issue; it’s a strategic choice. Kenya’s EMPOWER initiative highlights how partnership and digital innovation can create a step-change in women’s healthcare. It offers a blueprint to other African countries for public-private collaboration that drives systemic, equitable, and lasting change.”

Health is Resilience: Strengthening African Health systems

Throughout the 2026 Africa Press Day, speakers shared details of initiatives that are working to strengthen health systems, including:

  • Women’s Integrated Care Services (WICs) in Kenya and Côte d’Ivoire, pilot projects that integrate women’s cancer services into primary health care for greater efficiency.
  • Home grown pandemic preparedness efforts, including sustainable and integrated diagnostic facilities and laboratory networks.
  • African-led science – including genomics and local research – that is contributing to African health sovereignty.

Distributed by APO Group on behalf of Roche.

 

Health

Afreximbank President visits African Medical Centre of Excellence as the landmark health investment marks first year of transformative impact

Published

on

Afreximbank

In its first year of operation, AMCE has moved from vision to measurable impact, demonstrating how development finance can transform healthcare on the continent

ABUJA, Nigeria, July 6, 2026/APO Group/ –As part of his working tour of Nigeria and the wider region, Dr George Elombi, President and Chairman of the Board of Directors of African Export-Import Bank (Afreximbank) (www.Afreximbank.com), visited the African Medical Centre of Excellence (AMCE) in Abuja, reaffirming Afreximbank’s commitment to supporting the realisation of Africa’s health care sovereignty.

 

Developed by Afreximbank in partnership with King’s College Hospital, London, AMCE was established to help transform specialist healthcare delivery in Africa, by strengthening clinical capacity, advancing research and education, creating a sustainable ecosystem for world-class care on the continent and in turn, reducing dependence on medical travel abroad.

In its first year of operation, AMCE has moved from vision to measurable impact, demonstrating how development finance can transform healthcare on the continent.

The Centre has registered over 5,000 patients from more than 20 countries across four continents, underscoring its growing role as a regional and global referral centre for advanced specialist healthcare.

Beyond the numbers are lives already being transformed. During its first year, AMCE has achieved several important clinical milestones. The Centre delivered West Africa’s first Stereotactic Body Radiation Therapy (SBRT) for lung cancer, treating an octogenarian with a localised lung tumour using a highly precise, non-invasive technique that previously required many patients to travel abroad. The Centre also completed its first complex Triple Coronary Artery Bypass Grafting (CABG), demonstrating that advanced cardiac care can now be delivered to global standards within Africa. AMCE also successfully completed two Stem cell transplants.

The success of this Centre reflects the depth of talent assembled here and the pan-African spirit that underpins its service

Its advanced laboratory has processed more than 40,000 diagnostic tests and investigations, completed 10 open-heart surgeries and 11 cardiac surgical procedures under the cardiac programme, administered 99 catheterisation laboratory procedures, and 173 anaesthesia-supported procedures in just a year.

Additionally, the Centre has commenced Nuclear medicine services, with Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) imaging now available for bone scans, renograms, and perfusion scans, while Positron Emission Tomography/Computed Tomography (PET/CT) imaging is scheduled to commence later in the year.

Speaking during the visit, Dr. Elombi applauded the remarkable progress recorded by the Centre within its first year of operation, describing it as a compelling demonstration of African excellence, institutional resolve, and shared purpose. He stated: “The success of this Centre reflects the depth of talent assembled here and the pan-African spirit that underpins its service. The vision that inspired the conception and construction of this facility is the same conviction now being carried forward by the medical professionals delivering care to the continent. The AMCE provides health services and advances Africa’s health sovereignty while affirming our collective capacity to take responsibility for our own lives and future. The AMCE is a world-class quaternary healthcare facility delivering medical services of a standard that many would previously have sought beyond the continent. Nigerians, and citizens across Africa, must take full advantage of this facility—built by African institutions with the steadfast support of our governments.”

AMCE Chief Executive Officer, Brian Deaver, said Dr. Elombi’s visit marks an important milestone in the Centre’s journey and provides an opportunity to reflect on the impact AMCE has made in just one year.

“Our progress, from pioneering clinical achievements to earning growing trust across the region, demonstrates that Africa can build and sustain world-class centres of excellence. With Afreximbank’s continued vision and support, we remain committed to advancing patient care, research, education and innovation to strengthen health systems across the continent”.  Deaver noted.

Dr Elombi also toured key clinical departments, interacted with healthcare professionals and staff, and received updates on the Centre’s operational performance, clinical achievements and long-term expansion plans. He thanked the facilities’ employees for their commitment to building a new benchmark for specialist healthcare in Africa, noting that the Centre’s early achievements reflect the dedication, professionalism and shared vision of its workforce.

Today, AMCE employs more than 600 clinical and non-clinical professionals, representing 12 nationalities, and reflecting its growing reputation as a destination for highly skilled healthcare professionals. Earlier this year, the Centre also earned Great Place to Work® Certification, with 90 percent of employees affirming it is a great place to work.

Distributed by APO Group on behalf of Afreximbank.

Continue Reading

Health

Taiwan entrepreneur Time Light Care brings smart elderly care to mainland as silver economy gains ground

Published

on

Time Light Care

TIANJIN, CHINA – Media OutReach Newswire – 29 June 2026 – A smart elderly care enterprise branded Time Light Care, based in north China’s Tianjin, has developed a proprietary smart elderly care management platform, drawing on Taiwan’s long-term care experience and riding the momentum of the mainland’s silver economy.

The nursing homes, positioned as “community-embedded, small-to-medium scale, high-quality care” facilities, allow the elderly to stay in familiar surroundings while remaining close to family members.

On the technology front, the company has introduced millimeter-wave radar monitors for completely bedridden residents to track breathing, pulse, and heartbeat in real time, with automatic alerts sent to caregivers’ phones in case of any abnormality.

The company has also introduced accessible vehicles equipped with detachable automatic wheelchairs that go directly to the bedside, helping “suspended seniors”—those who struggle to go downstairs due to the lack of elevators—to go out with dignity.

These industry efforts come as China’s elderly population aged 60 and above reached 320 million by the end of 2025, a figure projected to exceed 400 million by 2035, with the silver economy expected to surpass 30 trillion yuan (about 4.41 trillion U.S. dollars).

In February 2026, an executive meeting of the State Council proposed to promote the expansion and quality improvement of inclusive elderly care service supply, improving a tiered, categorized, inclusive, accessible, urban-rural covering, and sustainable elderly care service system. The series of measures outlined at the meeting charted the direction and identified priorities for better meeting the diverse and multi-level needs of hundreds of millions of elderly people.

“The mainland’s policy support and market scale have created immense opportunities for innovation in senior care,” said Jing Ran, the company’s representative, during an exclusive interview with China News Service. “Having succeeded in starting our business here, we now hope to encourage more young people from Taiwan to come, explore, and develop their careers on the mainland.”

 

Continue Reading

Health

Vestergaard and LifeStraw team up to boost community health impact in Kenya

Published

on

Vestergaard

Vestergaard first rehabilitated the Emusanda Health Centre in Lurambi, Kenya, in 2009, establishing a community clinic delivering essential primary and paediatric care, and comprehensive services for people living with HIV

NAIROBI, Kenya, June 24, 2026/APO Group/ –Vestergaard (https://Vestergaard.com/) and LifeStraw – sister companies united by shared values and a long commitment to social impact – are strengthening their collaboration in western Kenya through a new annual commitment from Vestergaard to donate 1,000 PermaNet® Dual long-lasting insecticidal mosquito nets. The initiative builds on more than a decade of joint engagement at Emusanda Health Centre, as well as LifeStraw’s global Give Back programme to provide communities across Kenya and other countries around the world with safe water.

 

Vestergaard first rehabilitated the Emusanda Health Centre in Lurambi, Kenya, in 2009, establishing a community clinic delivering essential primary and paediatric care, and comprehensive services for people living with HIV. Since LifeStraw became an independent company in 2020, it has continued to develop the facility – building a maternity ward and strengthening pre- and postnatal services – while Vestergaard has provided mosquito nets for every mother giving birth at the centre, and every family with children under 5 years old accessing care. Each family also receives a LifeStraw household water purifier, and LifeStraw’s local teams continue to support the clinic by filling staffing gaps and supplying essential medicines so services can operate around the clock.

 

Beyond Emusanda, LifeStraw’s Give Back programme has delivered safe water to schools and communities across Kenya and other countries, reaching more than 14 million children. At the same time, malaria remains a major threat to child health, with over 4 million cases estimated nationwide in 2024. Insecticide‑treated nets have been instrumental in reducing malaria globally, accounting for 72% (https://apo-opa.co/4vuLfIc) of all cases prevented between 2000 and 2024, while next‑generation dual active‑ingredient nets including PermaNet Dual have stopped an estimated 40 million cases since their introduction in 2019.

Safe water and malaria prevention are two of the most fundamental building blocks of community health, yet too many families still lack consistent access to either

 

By integrating distribution of Vestergaard’s latest mosquito net technology into LifeStraw’s existing community health programmes, the annual donation of PermaNet Dual will extend protection beyond healthcare facilities to boarding schools caring for orphans and children with disabilities, ensuring safer nights for some of the most at risk. Together, safe drinking water and malaria prevention form a simple but powerful package of protection for mothers, newborns, and school‑aged children.

 

Amar Ali, CEO of Vestergaard, said: “LifeStraw’s frontline work continues to show where the gaps are, and how well‑targeted interventions can protect children who might otherwise be left behind. By formalizing this annual PermaNet donation, we’re reinforcing our shared commitment to helping communities access the basic tools they need for a safer and healthier start in life.”

 

Alison Hill, CEO of LifeStraw, said: “Safe water and malaria prevention are two of the most fundamental building blocks of community health, yet too many families still lack consistent access to either. LifeStraw’s mission has always been rooted in the belief that safe water is a foundation for health and opportunity, but water alone is not enough. By integrating Vestergaard’s PermaNet Dual into our programs, we are bringing together the right interventions for families and children, improving both health and educational outcomes. It is a practical, scalable approach grounded in decades of work in these communities.”

Distributed by APO Group on behalf of Vestergaard Sàrl.

 

Continue Reading

Trending